SecBot SecBot
SC 13G/A ·Filed Oct 9, 2026

IVF

INVO Fertility, Inc.
BEARISH
Impact 4/10
Horizonweeks Processed18d 4h ago SEC0000902664-26-004117
Passive stake amendment
Actionable Insight ▼ Bearish

Glenbrook's reduction is modest but breaks a prior accumulation trend. Monitor for further sales or a potential exit; a drop below 5% would remove a known supportive holder. The passive 13G filing limits activist risk.

DirectionBearish
Confidencemedium
Horizonweeks
Latest settled — T+5d
IVF ▼ -23.35% at T+5d
SHORT call ✓ call won +23.35% · α vs SPY +21.39% · entry $0.7275 → $0.5576
Next anchor: T+20d in 10d
Latest observation: T+10 +14.27% FF3 residual α
Entry = T+0 close
Oct 9, 2026
via day close
T+1d
-0.21%
call +0.21% · α +0.15%
$0.7260
settled 15d ago
T+5d
-23.35%
call +23.35% · α +21.39%
$0.5576
settled 11d ago
T+20d
Pending
in 10d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Glenbrook Capital Management filed an amended Schedule 13G reporting a reduction in its stake in INVO Fertility, Inc. As of September 30, 2026, Glenbrook beneficially owned 35,000 shares (1.4% of shares outstanding), down from 40,000 shares (1.7%) as of June 30, 2026. The filing reaffirms passive intent, but the reduction signals modest de-risking by a long-term holder.

Key Financial Metrics

Stake
1.4%
Investor
Glenbrook Capital Management

Key Facts

  • Glenbrook Capital Management reported beneficial ownership of 35,000 shares of INVO Fertility common stock as of September 30, 2026.
  • This represents 1.4% of the 2,506,969 shares outstanding as of August 14, 2026.
  • The stake decreased from 40,000 shares (1.7%) as of June 30, 2026.
  • The filing is an amendment to a Schedule 13G, indicating passive investment intent.
  • The filing date is October 9, 2026.

Financial Impact

Stake reduced by 5,000 shares (12.5% of Glenbrook's prior position), from 1.7% to 1.4% of outstanding shares.

ownership percentageshare count

Risk Factors

  • Further selling by Glenbrook could pressure the stock.
  • Low trading liquidity may amplify the impact of any additional sales.
  • The company's small market cap makes it sensitive to changes in holder sentiment.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000902664-26-004117
Document: 0000902664-26-004117-index.html0000902664-26-004117
Document: 0000902664-26-004117.txt0000902664-26-004117
15 reports for IVF
Performance horizon
71% Hit rate @ T+5 5 of 7 directional calls Went positive at some point 6 of 7 best @ T+60▲ +39.41%Jun 2, 2026
Filters
Rows
Reports for IVF — sortable, filterable
TypeNow
Oct 27, 2026
today
Press Release
NEUTRAL ★ 3/10
$0.5618awaiting T+5—$0.6161 (+9.67%)
Oct 9, 2026
18d ago
SC 13G/A
BEARISH ★ 4/10
$0.7275 $0.5576▲ +23.35%▲ +21.39%$0.6161 (+15.31%)
Aug 28, 2026
8w ago
8-K
BEARISH ★ 6/10
$1.00 $0.9850▲ +1.50%▲ +1.61%$0.6161 (+38.39%)
Aug 17, 2026
10w ago
8-K
NEUTRAL ★ 4/10
$1.53 $1.03▼ −32.68%▼ −31.49%$0.6161 (−59.73%)
Aug 17, 2026
10w ago
Press Release
BEARISH ★ 6/10
$1.53 $1.03▲ +32.68%▲ +31.49%$0.6161 (+59.73%)
Aug 5, 2026
11w ago
EFFECT
BEARISH ★ 5/10
$1.08 $1.01▲ +6.05%▲ +6.40%$0.6161 (+42.69%)
Jun 25, 2026
17w ago
8-K
NEUTRAL ★ 4/10
$2.45 $1.62▼ −33.88%▼ −36.04%$0.6161 (−74.85%)
Jun 22, 2026
18w ago
Press Release
BEARISH ★ 7/10
$1.39 $2.45▼ −76.26%▼ −78.33%$0.6161 (+55.68%)
Jun 16, 2026
19w ago
8-K
NEUTRAL ★ 2/10
$1.59 $1.32▼ −16.98%▼ −15.94%$0.6161 (−61.25%)
Jun 2, 2026
21w ago
Press Release
BEARISH ★ 6/10
$1.70 $1.41▲ +17.06%▲ +13.24%$0.6161 (+63.76%)
Showing 10 of 15

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 9, 2026